Medizen Humancare Inc Co., Ltd Logo

Medizen Humancare Inc Co., Ltd

Offers DTC genetic testing and genomic analysis for personalized disease risk prediction.

236340 | KO

Overview

Corporate Details

ISIN(s):
KR7236340006
LEI:
Country:
South Korea
Address:
서울특별시 송파구 정의로7길 6 PNS홈즈타워 6층, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Medizen Humancare Inc Co., Ltd. is a biotechnology research company specializing in genomics-based personalized healthcare. Established in 2012, the company's core business is genomic analysis to predict individual disease risks. It provides direct-to-consumer (DTC) genetic testing and disease risk analysis services using genetic chips and analysis kits. By leveraging genomic big data, Medizen Humancare aims to advance precision medicine and deliver customized healthcare solutions based on an individual's genetic information.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-13 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.7 KB
2025-04-28 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.1 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 16.2 KB
2025-03-21 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.1 MB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 10.4 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 143.7 KB
2025-02-24 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 6.8 KB
2024-12-31 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 31.5 KB
2024-12-23 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 71.6 KB
2024-12-13 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-04 00:00
Regulatory News Service
기업설명회(IR)개최결과
Korean 6.7 KB
2024-10-21 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.1 KB
2024-08-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 79.2 KB
2024-06-26 00:00
Related Party Transaction
타법인주식및출자증권취득결정
Korean 13.7 KB
2024-06-26 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 35.4 KB

Automate Your Workflow. Get a real-time feed of all Medizen Humancare Inc Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medizen Humancare Inc Co., Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Medizen Humancare Inc Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America
APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea
397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.